- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/38 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 333/38
Total number of patents in this class: 704
10-year publication summary
|
38
|
42
|
46
|
48
|
40
|
50
|
54
|
34
|
38
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2204 |
31 |
| Takeda Pharmaceutical Company Limited | 2717 |
28 |
| Bayer AG | 3465 |
19 |
| BASF SE | 21150 |
10 |
| Astellas Pharma Inc. | 1036 |
10 |
| Nissan Chemical Industries, Ltd. | 1662 |
8 |
| AstraZeneca AB | 2823 |
7 |
| EA Pharma Co., Ltd. | 93 |
7 |
| Boehringer Ingelheim International GmbH | 4494 |
6 |
| Bayer Cropscience AG | 1879 |
6 |
| Bayer Pharma AG | 1025 |
6 |
| Vertex Pharmaceuticals Incorporated | 1590 |
6 |
| Alcon, Inc. | 5750 |
6 |
| Global Blood Therapeutics, Inc. | 176 |
6 |
| Kissei Pharmaceutical Co., Ltd. | 177 |
6 |
| Corteva Agriscience LLC | 2640 |
6 |
| Syngenta Crop Protection AG | 6570 |
5 |
| ADAMA Agan Ltd. | 432 |
5 |
| Incyte Corporation | 1063 |
5 |
| Xwpharma Ltd. | 64 |
5 |
| Other owners | 516 |